Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Financings In Brief

This article was originally published in The Gray Sheet

  • News

Executive Summary

Device VC activity increases

You may also be interested in...



St. Jude Outlines Strategy To Revive Pacemaker Business

St. Jude Medical’s pacemaker revenue dropped 12 percent year-over-year in the first quarter, but the firm says it has several products in the pipeline that could help it regain pacemaker market share in Europe and Japan.

Samsung Electronics Denies Takeover Of Israeli Medical Device Maker OrSense

SEOUL - Samsung Electronics denied a local newspaper report June 2 that it is seeking to buy Israeli medical device maker OrSense Ltd.

Shire Nabs Advanced BioHealing Just Prior To Planned IPO

Just before its planned debut on the New York Stock Exchange, wound healing device maker Advanced BioHealing Inc. instead agreed to a $750 million buyout offer May 17 from drug maker Shire PLC, which has a history of using acquisitions to jump quickly into new lines of business.

Table

View full table

Related Content

Medtech Insight
Medtech Insight
Tags:
Latest Headlines

Octave Biosciences Takes It Up Another Semitone With Michael J Fox Foundation Grant

Member States Want Action Over High-Risk IVDs and Eudamed Medical Device Database

J&J Will Pay At Least $400m For Laminar To Add Stroke-Stopping Technology

‘One Little Cog’: Former J&J Attorney Discusses Return To Private Practice

See All
UsernamePublicRestriction

Register

MT030141

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By